New classification of gastrointestinal stromal tumors guides precision treatment
More information: Feifei Xie et al, Genomic and transcriptomic landscape of human gastrointestinal stromal tumors, Nature ...
Business Wire1 个月
IDRx Announces Updated Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial of IDRX-42 ...
Presentation Details Title: The Novel KIT inhibitor IDRX-42 Shows Promising Activity in Second- and Later-Line Gastrointestinal Stromal Tumors (GIST): Results from a Phase 1 Trial (StrateGIST 1 ...